Combined Effect of Continuous Glucose Monitoring and Semaglutide: Analysis of Administrative Claims
Claims data reveal larger hemoglobin A1c decreases in people with type 2 diabetes who use continuous glucose monitoring and semaglutide compared with semaglutide alone.
Resource Utilization With Insulin Pump Therapy for Type 2 Diabetes Mellitus
A retrospective claims analysis of managed care enrollees with type 2 diabetes mellitus showed that insulin pump therapy reduced antidiabetic drug and healthcare resource use.